GAUDIUMIVF (9)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NSE adds 7 securities to ESM Stage I with minimum 100% margin requirement effective April 28, 2026, shifting them from Rolling Settlement to … | |||||||||||||||
NSE adds 7 securities to ESM Stage I with minimum 100% margin requirement effective April 28, 2026, shifting them from Rolling Settlement to Trade-for-Trade segment. One security (CURAA) moves from Stage II back to Stage I.
| |||||||||||||||
NSE Short-Term Additional Surveillance Measure (ST-ASM) - Stage I Inclusion Effective April 17, 2026 NSE places 13 securities under ST-ASM Stage I effective April 17, 2026, requiring minimum 50% margin on all open and new positions from … | |||||||||||||||
NSE places 13 securities under ST-ASM Stage I effective April 17, 2026, requiring minimum 50% margin on all open and new positions from April 20, 2026. No securities are added to Stage II.
| |||||||||||||||
NSE announces transfer of Gaudium IVF and Women Health Limited (GAUDIUMIVF) from trade-for-trade segment (Series BE) to rolling segment … | |||||||||||||||
NSE announces transfer of Gaudium IVF and Women Health Limited (GAUDIUMIVF) from trade-for-trade segment (Series BE) to rolling segment (Series EQ) effective March 16, 2026, following IPO listing.
| |||||||||||||||
BSE announces the upcoming listing of equity shares of Gaudium IVF and Women Health Limited (scrip code 544709, symbol GAUDIUMIVF) on the … | |||||||||||||||
BSE announces the upcoming listing of equity shares of Gaudium IVF and Women Health Limited (scrip code 544709, symbol GAUDIUMIVF) on the Exchange. The exact listing date will be communicated via a separate notice.
| |||||||||||||||
BSE informs trading members that equity shares of Gaudium IVF and Women Health Limited (Scrip Code: 544709, Symbol: GAUDIUMIVF) will be … | |||||||||||||||
BSE informs trading members that equity shares of Gaudium IVF and Women Health Limited (Scrip Code: 544709, Symbol: GAUDIUMIVF) will be listed on the Exchange in due course, with the exact listing date to be announced separately.
| |||||||||||||||
BSE announces the upcoming listing of equity shares of Gaudium IVF and Women Health Limited (Scrip Code: 544709, Symbol: GAUDIUMIVF) on the … | |||||||||||||||
BSE announces the upcoming listing of equity shares of Gaudium IVF and Women Health Limited (Scrip Code: 544709, Symbol: GAUDIUMIVF) on the SME segment. The exact listing date will be communicated via a separate notice.
| |||||||||||||||
BSE announces the forthcoming listing of equity shares of Gaudium IVF and Women Health Limited (scrip code 544709, symbol GAUDIUMIVF). The … | |||||||||||||||
BSE announces the forthcoming listing of equity shares of Gaudium IVF and Women Health Limited (scrip code 544709, symbol GAUDIUMIVF). The exact listing date will be communicated via a separate notice.
| |||||||||||||||
NSE announces the forthcoming listing of Gaudium IVF and Women Health Limited (symbol: GAUDIUMIVF) on the exchange under ISIN INE0P8B01020. … | |||||||||||||||
NSE announces the forthcoming listing of Gaudium IVF and Women Health Limited (symbol: GAUDIUMIVF) on the exchange under ISIN INE0P8B01020. The exact listing date will be communicated via a separate circular.
| |||||||||||||||
NSE notifies the listing of equity shares of Gaudium IVF and Women Health Limited on the Capital Market segment effective February 27, 2026, … | |||||||||||||||
NSE notifies the listing of equity shares of Gaudium IVF and Women Health Limited on the Capital Market segment effective February 27, 2026, with 72,786,884 shares at an issue price of Rs. 79 per share.
| |||||||||||||||